Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
8H9 mAb
print preview
bookmark
share with colleague
General Information
Company
United Therapeutics Corp.
Description
8H9 monoclonal antibody (mAb) with specificity for B7-H3 antigen
Molecular Target
B7-H3 (CD276)
Mechanism of Action
Antibody
Latest Stage of Development
Phase I
Indication
Brain cancer
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information